Roche Pharma India announces recipients of 2nd Edition of LEAP Scholarship Prog

IMT News Desk
IMT News Desk
· 2 min read

Each winner was awarded Rs 3 lakh scholarship, a certificate, and a medal for their contributions to advancing academic excellence in oncology

Roche Pharma India announced the winners of the second edition of the Leading Engagements to Advance Patient Care (LEAP) program. The felicitation ceremony celebrated five outstanding oncology students, whose solutions addressed challenges in the field of cancer care.  

The second edition of LEAP invited all streams of final-year oncology students enrolled in super-speciality courses such as DM/DNB/MCh to provide solutions across clinical care, immunotherapy, patient care, and other areas such as innovation and access. This edition attracted participation from 100+ leading medical colleges and hospitals nationwide, with 256 innovative solutions being submitted. The five winners from this year include:

  • Dr Beulah Elizabeth Koshy from Kidwai Memorial Institute of Oncology, Bengaluru, whose solution focussed on palliative support and ethical decision-making, earning jury recognition for its emphasis on compassionate care and patient dignity
  • Dr Ruhi Kumar of Stanley Medical College, Chennai, who developed an affordable caregiving support model that enhanced treatment adherence and was lauded for its patient-centric approach
  • Dr Prabhu Pandian of Madurai Medical College, Madurai, who introduced a standardized MDT platform for personalized cancer care plans, enabling real-time adjustments, earning praise for its structured, evidence-driven methodology
  • Dr Athira Vincent of Regional Cancer Centre, Thiruvananthapuram, whose AI platform for accurate cancer diagnosis, personalized treatment and real-time monitoring stood out for its potential to transform cancer care
  • Dr Soumya BM of Manipal Hospital, Bengaluru, whose solution focused on access programs, tiered pricing models and partnerships for affordable medications and technologies  

Each winner was awarded Rs 3 lakh scholarship, a certificate, and a medal for their contributions to advancing academic excellence in oncology. This year’s felicitation event was graced by deans of medical colleges and renowned oncologists, creating a highly engaging experience.

“LEAP program is a testament of our commitment to reimagining healthcare, aligned with the vision of Viksit Bharat, by investing and nurturing in the next generation of India’s medical talent. The winners and participants of this program are not only addressing today’s oncology challenges with creativity and compassion, but are the future architects of a more compassionate approach to cancer care in India which is more human, inclusive, and accessible”, said Roche Pharma India CEO & Managing Director, Rajwinder Mehdwan.

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk